日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.

开发一种新型制剂,以提高富马酸替诺福韦酯的临床前生物利用度

Watkins Melynda E, Wring Steve, Randolph Ryan, Park Seonghee, Powell Kendall, Lutz Lissa, Nowakowski Michelle, Ramabhadran Ram, Domanico Paul L